News Conference News AHA 2024 Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression Yael L. Maxwell November 20, 2024
News Conference News TVT 2023 Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI Shelley Wood June 14, 2023
News Conference News TVT 2023 ‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients Michael O'Riordan June 09, 2023
News Conference News AHA 2022 CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis Yael L. Maxwell November 05, 2022
News Conference News TCT 2022 Valve Fracture for ViV TAVI Linked With Higher Mortality Michael O'Riordan September 22, 2022
News Conference News HFSA 2019 Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF L.A. McKeown September 23, 2019